EAM
CLVS

Eventide Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Eventide Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-28,300
Closed -$1.96M – 112
2014
Q1 		$1.96M Buy
+28,300
New +$2.08M 0.3% 68

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Eventide Asset Management's CLVS Position: Q2 2014 in Review

Eventide Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2014, closing a stake of 28,300 shares — an estimated $1.96M sold.

Eventide Asset Management first reported a position in CLVS in Q1 2014 and held it in 1 quarter. The position peaked at $1.96M in Q1 2014. 140 funds tracked by Wall St. Rank hold CLVS as of Q2 2014.

  • Eventide Asset Management reported no remaining Clovis Oncology, Inc. position as of Q2 2014 after selling out during the quarter.
  • Eventide Asset Management sold 28,300 Clovis Oncology, Inc. shares in Q2 2014, an estimated $1.96M.
  • Eventide Asset Management first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 1 quarter.
  • Eventide Asset Management's Clovis Oncology, Inc. position peaked at $1.96M in Q1 2014.
  • 140 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2014.

Based on Eventide Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.